Sanofi pays $300m upfront to expand deal with Translate Bio
The firms are working on the development of mRNA vaccines
Read More
Tag: Sanofi Pasteur
Trivalent gets UK green light for flu in over 65s
UK marketing authorisation has been granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose for people 65 years and older.
Read More
AZ and Sanofi link on RSV vaccine
AstraZeneca’s MedImmune is partnering with Sanofi’s vaccines arm Sanofi Pasteur on the development and commercialisation of its experimental monoclonal antibody MEDI8897 for the prevention of Respiratory Syncytial Virus (RSV) associated illness in newborns and infants.
Read More
Sanofi names chief of standalone vaccines unit
Sanofi has named Hugo Fry as general manager for the UK and general manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert Bland as UK medical chair and medical head of diabetes and cardiovascular for the UK & Ireland.
Read More
Sanofi Pasteur MSD’s shingles jab OK’d for UK’s immunisation scheme
Sanofi Pasteur MSD’s shingles (herpes zoster) vaccine has been cleared for continued use in the UK’s national immunisation programme for at least the next two years, following an evaluation of the vaccine’s clinical and cost effectiveness.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
